# \[Results of randomized, multicenter, double-blind phase III trial of rh-endostatin (YH-16) in treatment of advanced non-small cell lung cancer patients\].

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/results-of-randomized-multicenter-double-blind-phase-iii-trial-of-rh-endostatin/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Jinwan Wang,Yan Sun,Yu Liu,Qitao Yu,Yiping Zhang,Kai Li,Yunzhong Zhu,Qinghua Zhou,Mei Hou,Zhongzhen Guan,Weilian Li,Wu Zhuang,Donglin Wang,Houjie Liang,Fengzhan Qin,Huishan Lu,Xiaoqing Liu,Hong Sun,Yanjun Zhang,Jiejun Wang,Suxia Luo,Yang Ruihe,Yuanrong Tu,Xiuwen Wang,Shuping Song,J. Zhou,Lifen You,Jing Wang,Yao Chen |
| Citations | 147 |
| DOI | 10.3779/j.issn.1009-3419.2005.04.07 |
| Open Access | false |
| OA Status | closed |
| OpenAlex ID | https://openalex.org/W1775905963 |
| PMID | 21108883 |
| Type | other |
| Year | 2005 |

## Paper authors

- [Kai Li](https://scholariq.org/researchers/kai-li/)

## Paper journal

- [PubMed](https://scholariq.org/journals/pubmed/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.